top of page

The rapid innovation response to COVID-19 and the role of IP


  1. “About the Oxford COVID-19 Vaccine,” July 19, 2020.

  2. “AstraZeneca Advances Response to Global COVID-19 Challenge as It Receives First Commitments for Oxford’s Potential New Vaccine.” Accessed July 16, 2021.

  3. “AstraZeneca Receives $1.2 Billion BARDA Contract for COVID-19 Vaccine,” May 22, 2020.

  4. Couronne, Ivan. “Pre-Orders of COVID-19 Vaccine Top Five Billion.” Medical Press, 2020.

  5. “COVID-19 Vaccine Doses Shipped by the COVAX Facility Head to Ghana, Marking Beginning of Global Rollout,” February 24, 2021.

  6. Finch, Hannah. “The Factories Making AstraZeneca, Pfizer and Other Covid-19 Vaccine in the UK.” Business Live, January 27, 2021.

  7. Gross, Anna. “AstraZeneca Agrees German Manufacturing Deal to Fill Vaccine Gap.” Financial Times, February 10, 2021.

  8. McKeever, Vicky. “AstraZeneca Receives $1 Billion in U.S. Funding for Oxford University Coronavirus Vaccine.” CNBC, May 21, 2020.

  9. ReliefWeb. “UNICEF Signs COVID-19 Vaccine Supply Agreement with AstraZeneca - World,” February 26, 2021.

  10. Triggle, Nick. “Covid: Under-30s Offered Alternative to Oxford-AstraZeneca Jab.” BBC News, April 7, 2021, sec. Health.

  11. Zimmer, Carl, Jonathan Corum, and Sui-Lee Wee. “Coronavirus Vaccine Tracker.” The New York Times, sec. Science. Accessed July 3, 2021.

bottom of page